Showing 5,661 - 5,680 results of 8,597 for search 'effective dysfunction', query time: 0.17s Refine Results
  1. 5661

    Is Senolytic Therapy in Cardiovascular Diseases Ready for Translation to Clinics? by Zhihong Yang, Duilio M. Potenza, Xiu-Fen Ming

    Published 2025-04-01
    “…However, recent studies have reported controversial results or detrimental effects caused by senolytic therapeutic approaches, including worsening of cardiac dysfunction, instability of atherosclerotic plaques, and even an increase in mortality in animal models, which challenges the translation of senolytic therapy into the clinical practice. …”
    Get full text
    Article
  2. 5662

    Fasting the mitochondria to prevent neurodegeneration: the role of ceramides by Luis Armando Valenzuela-Ahumada, Octavio Fabián Mercado-Gómez, Rubi Viveros-Contreras, Rosalinda Guevara-Guzmán, Alberto Camacho-Morales

    Published 2025-06-01
    “…Preclinical and clinical advances have documented that altered energy homeostasis and mitochondria dysfunction is a hallmark of neurological disorders. …”
    Get full text
    Article
  3. 5663

    Exercise and dietary interventions in the management of diabetic cardiomyopathy: mechanisms and implications by Ling Zhong, Xiaojie Hou, Yan Tian, Xianghui Fu

    Published 2025-04-01
    “…Despite advances in pharmacological therapies, the effectiveness of managing cardiac dysfunction in DCM remains challenging. …”
    Get full text
    Article
  4. 5664

    Molecular Mechanisms and Signaling Pathways Underlying the Therapeutic Potential of Thymoquinone Against Colorectal Cancer by Amin F. Majdalawieh, Saud Al-Samaraie, Tala M. Terro

    Published 2024-12-01
    “…It causes mitochondrial dysfunction and activates caspases, contributing to its pro-apoptotic effects. …”
    Get full text
    Article
  5. 5665

    4-Hydroxy-2-nonenal Induces Apoptosis by Inhibiting AKT Signaling in Human Osteosarcoma Cells by Guang-rong Ji, Nai-chun Yu, Xiang Xue, Zong-guang Li

    Published 2014-01-01
    “…The onset of lipid peroxidation within cellular membranes is associated with changes in their physiochemical properties and enzymatic dysfunction of the membrane environment. There are increasing bodies of evidence indicating that aldehydic molecules generated endogenously during the process of lipid peroxidation are causally involved in most of the pathophysiological effects associated with oxidative stress in cells and tissues. 4-Hydroxy-2-nonenal (4-HNE), among them, is believed to be largely responsible for cytopathological effects observed during oxidative stress in vivo and has achieved the status of one of the best recognized and most studied of the cytotoxic products of lipid peroxidation. …”
    Get full text
    Article
  6. 5666
  7. 5667

    Results of Emollient Therapy in a Child with Severe Atopic Dermatitis Treated with Genetically Engineered Biological Drug: Clinical Case by Eduard T. Ambarchyan, Anastasiya D. Alekseeva, Vladislav V. Ivanchikov

    Published 2025-05-01
    “…This clinical case confirms the feasibility of therapy with emollient-plus agents, as it was possible to achieve the correction of epidermal barrier dysfunction and significant clinical effect.…”
    Get full text
    Article
  8. 5668

    Vildagliptin and its role in the treatment of diabetes mellitus by Yury Shavkatovich Khalimov

    Published 2010-09-01
    “…Results of international clinical studies show that Galvus and GalvusMet are efficacious and safe, they ensure adequate control of glycemiafree from complications and side effects. An important advantage of these preparations is the possibility of their use by elderly patients with arterialhypertension and moderate renal dysfunction and by those at risk of cardiovascular disorders. …”
    Get full text
    Article
  9. 5669

    Impairing the interaction between Erg11 and cytochrome P450 reductase Ncp1 enhances azoles’ antifungal activities by Wanqian Li, Malcolm Whiteway, Sijin Hang, Jinhua Yu, Hui Lu, Yuanying Jiang

    Published 2025-07-01
    “…Abstract Azole effectiveness against candidiasis can be compromised by Candida albicans resistance and tolerance, and unfortunately, few clinically useful compounds can enhance azole antifungal activities. …”
    Get full text
    Article
  10. 5670
  11. 5671

    Overview of oxidative stress and inflammation in diabetes by Roni Weinberg Sibony, Omri Segev, Saar Dor, Itamar Raz

    Published 2024-10-01
    “…This review explores the effect of T2D on target organ damage and potential treatments to minimize this damage. …”
    Get full text
    Article
  12. 5672

    The Pathogenesis of Oxidative Stress-Induced Chloasma and Its Therapeutic Implications by Wu Q, Zheng H, Wu J, Tang Y, Cheng H

    Published 2025-04-01
    “…However, the therapeutic efficacy of these treatments often falls short of patients’ expectations and is accompanied by notable side effects. Oxidative stress, characterized by an imbalance between oxidation and antioxidation, plays a crucial role in various clinical conditions and leads to oxidative damage, including cellular dysfunction, DNA damage, protein and lipid peroxidation, and even irreversible cell death. …”
    Get full text
    Article
  13. 5673

    Interleukin-4 prevents increased endothelial permeability by inducing pericyte survival and modulating microglial responses in diabetic retinopathy by Jang-Hyuk Yun

    Published 2025-07-01
    “…Pericyte loss and microglia-mediated inflammation exacerbate this vascular dysfunction. Interleukin-4 (IL-4) is known for its anti-inflammatory and tissue-protective properties, but its role in DR remains unclear. …”
    Get full text
    Article
  14. 5674

    Trichostatin A suppresses hearing loss by reducing oxidative stress and inflammation in an Alport syndrome model. by Yoon Seok Nam, Eun-Ji Gi, Yoo-Seung Ko, Sungsu Lee, Hyong-Ho Cho

    Published 2025-01-01
    “…HDAC inhibitors (HDACis) are chemical compounds that block the activity of histone deacetylase and are known to exert diverse biologic effects. We investigated the effect of Trichostatin A (TSA), an HDACi, to assess its potential to inhibit hearing deterioration in AS. …”
    Get full text
    Article
  15. 5675

    Sequential administration of efgartigimod shortened the course of Guillain–Barré syndrome: a case series by Sihui Chen, Ruwei Ou, Qianqian Wei, Bi Zhao, Xueping Chen

    Published 2025-02-01
    “…This case series investigates the effects of sequential efgartigimod administration in patients with different GBS phenotypes and varying levels of disease severity. …”
    Get full text
    Article
  16. 5676

    Local and Systemic Pathogenesis and Consequences of Regimen-Induced Inflammatory Responses in Patients with Head and Neck Cancer Receiving Chemoradiation by Elvio G. Russi, Judith E. Raber-Durlacher, Stephen T. Sonis

    Published 2014-01-01
    “…In addition, the finding that patients commonly develop toxicities representing tissue injury outside radiation fields and side effects such as fatigue or cognitive dysfunction suggests the generation of systemic as well as local mediators. …”
    Get full text
    Article
  17. 5677
  18. 5678

    Research Progress on the Role of Puerarin in the Prevention and Treatment of Alzheimer's Disease by Changsong Chu, Yaquan Jia, Yuan Liu, Ruofei Du, Zichuang Wang, Zhenqiang Zhang, Wanchun Zheng, Junying Song

    Published 2025-03-01
    “…It exerts potential therapeutic effects in multiple aspects, including regulating the expression of amyloid β-protein (Aβ), inhibiting abnormal phosphorylation of microtubule-associated protein-τ (Tau), scavenging free radicals, resisting oxidation, regulating metal metabolism to maintain cholinergic system stability, improving mitochondrial dysfunction, and resisting inflammation. …”
    Get full text
    Article
  19. 5679

    Berberine and its derivatives: mechanisms of action in myocardial vascular endothelial injury - a review by Wenhui Zhang, Siyi Guo, Jinjin Dou, Xiwu Zhang, Fan Shi, Chun Zhang, Huxiao Zhang, Xiaodong Lan, Yi Su

    Published 2025-03-01
    “…Mechanisms such as endoplasmic reticulum stress, apoptosis, inflammation, oxidative stress, autophagy, platelet dysfunction, and gut microbiota imbalance are intimately linked to this condition. …”
    Get full text
    Article
  20. 5680

    The Immune Microenvironment: New Therapeutic Implications in Organ Fibrosis by Xiangqi Chen, Chuan Wu, Fei Tang, Jingyue Zhou, Li Mo, Yanping Li, Jinhan He

    Published 2025-08-01
    “…Abstract Fibrosis, characterized by abnormal deposition of structural proteins, is a major cause of tissue dysfunction in chronic diseases. The disease burden associated with progressive fibrosis is substantial, and currently approved drugs are unable to effectively reverse it. …”
    Get full text
    Article